BIOABs is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0.4%.On average, the company has surpassed earnings expectations by 0.3198%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on LSE (SEK).